Grozījumi Ministru kabineta 2003.gada 29.aprīļa noteikumos Nr.235 'Dzeramā ūdens obligātās nekaitīguma un kvalitātes prasības, monitoringa un kontroles kārtība'

Latvijas Vēstnesis, May 22, 2008 (Nbr. 79)

Dokumenti
Permanent Link: http://lv.vlex.com/vid/29-oblig-tes-monitoringa-kontroles-k-ba-50126497
Id. vLex: VLEX-50126497

Acceda a este documento
y pruebe vLex GRATIS durante 3 días

Sponsored Ads:


Summary:

Ministru kabineta noteikumi Nr.342

Extract:

Grozījumi Ministru kabineta 2003.gada 29.aprīļa noteikumos Nr.235 'Dzeramā ūdens obligātās nekaitīguma un kvalitātes prasības, monitoringa un kontroles kārtība'

Ministru kabineta noteikumi Nr.342

Rīgā 2008.gada 19.maijā (prot. Nr.31 33.§)

Grozījumi Ministru kabineta 2003.gada 29.aprīļa noteikumos Nr.235 "Dzeramā ūdens obligātās nekaitīguma un kvalitātes prasības, monitoringa ...



Activate your free trial now

Make your order

Need help? Contact us

Try vLex for FREE for 3 days

Access legal information from Latvia including:

  • Legal Books and Journals
  • Case Law
  • Legislation

Try vLex without any commitment for 3 days and see why you need it.

3

days of Free Access



If you are already a vLex customer, Access Here

Sponsored Ads:


Other documents:
Par licences Nr.43031 saskidrinatas gazes sadalei anulesanu SIA 'LANALS' | Dokumentu zimogu atsaukumi | Pazinojumi par teritorijas planosanu | Iepirkumi valsts un pašvaldību vajadzībām | 22 CFR 130.10 Information to be furnished by applicant or supplier to the Office of Defense Trade Controls. | 18 CFR 1304.406 - Removal of unauthorized, unsafe, and derelict structure... | 29 cfr 3.4 - submission of weekly statements and the preservation and inspection of weekly payroll records. | 32 CFR 253.5 Responsibilities. | 21 CFR 314.53 - Submission of patent information. | 10 CFR 765.12 - Inflation index adjustment procedures. | 24 CFR 200.1540 Imminent harm notice of action. | 32 cfr 776.30 - successive government and private employment. | 26 CFR 1.955-5 - Definition of less developed country corporation. | 21 CFR 320.22 Criteria for waiver of evidence of in vivo bioavailability or bioequivalence.